drugset / Trial / NCT02480764
Azilsartan Medoxomil (TAK-491) Compared to Valsartan in Chinese Participants With Hypertension
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the antihypertensive effect of azilsartan medoxomil compared with valsartan in Chinese participants with essential hypertension.
Timeline
- Start
- 2015-08-27
- Primary completion
- 2017-09-22
- Completion
- 2017-10-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Azilsartan medoxomil | Other / unclassified | 40 mg | Oral |
| Subject | Azilsartan medoxomil | Other / unclassified | 80 mg | Oral |
| Subject | Valsartan | Small molecule | 160 mg | Oral |